Federal Circuit invalidated patents on blockbuster Amgen cholesterol drug U.S. Solicitor General says decision was reasonable (Reuters) - The Biden Administration told the U.S. Supreme Court on ...
After Amgen last year asked the Supreme Court to take up its long-running PCSK9 patent feud with Sanofi and Regeneron, the High Court turned to the federal government to weigh in. Now, the Biden ...
Most Medicare Part D plans include coverage for Repatha, though specific coverage details can vary among plans. Out-of-pocket costs for Repatha under Medicare Part D typically average around $49 per ...
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha ® (evolocumab) to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results